Effecta pacemaker series
BIOTRONIK has an unsurpassed legacy of quality that leads to the most effective therapy solutions. Our latest pacemaker technology Effecta continues to set new standards. A 33% reduction of components represents a more technically efficient product design. At the same time, battery longevity is extended using novel, efficient, integrated circuitry that cuts energy consumption by 50%. Quality design. Unmatched reliability. That's the foundation for “excellence for life.”
Essential therapy for a broad range of patients Promotion of intrinsic rhythm with the new IRSplus - IRSplus promotes intrinsic conduction with a full hysteresis package and reduces pacing by 94%1
Detection and management of atrial fibrillation with IEGM and AutoSensing® - Two IEGM triggers responding to atrial fibrillation
- Enhanced mode switching with AutoSensing®
Enhanced safety with full automaticity Effective pacing outputs with Atrial & Ventricular Capture Control - Beat-by-beat ventricular back-up pulses
- User defined search timing
- Automatic threshold test during follow-up
Verified lead integrity with Auto Lead Check - Subthreshold impedance measurements every 30 seconds
Superior longevity designed to last beyond a decade Reduced circuitry energy consumption and state-of-the-art battery technologies result in - Longevity of 12.1 years2
- Reduced risks associated with device replacements
Ease of use during implantation and follow-up Advanced automaticity makes pacemaker implantation and follow-up easier than ever - Auto-Initialization activates essential pacemaker functions and follow-up data within 10 minutes
- The Effecta Follow-up Center summarizes all necessary data, including measurements on one follow-up page
1 Weyerbrock et al; Eur Heart J 2008; 29 (Abstract supplement): 416. 2 Effecta DR: A/V: 2.5 V, 0.4 ms, 60 ppm, 500 Ω |
